Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common leading causes of cancer death worldwide. As most patients are diagnosed with advanced disease, systemic therapy remains the backbone of treatment. In recent years, we have witnessed the transformation of advanced HCC treatment landscapes from...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanuso, Valentina, Pirozzi, Angelo, Balsano, Rita, Pressiani, Tiziana, Rimassa, Lorenza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557510/
https://www.ncbi.nlm.nih.gov/pubmed/37808223
http://dx.doi.org/10.2147/JHC.S347932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557510/
https://www.ncbi.nlm.nih.gov/pubmed/37808223
http://dx.doi.org/10.2147/JHC.S347932

Ejemplares similares